ORGO vs PRU · rev $81.0M vs rev $31.19B
Organogenesis Holdings Inc (ORGO) versus PRU (PRU) — a side-by-side from cached financials, not a winner call.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
PRU (PRU) common stock.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
Latest reported PRU revenue for 2026-06-30 was $31.19B. Net income was $1.58B. PRU currently screens at market cap $0.
ORGO currently screens at market cap $301.1M. PRU currently screens at market cap $0.
Not investment advice. Open the ORGO and PRU stock pages for the full models.
Not investment advice.